Mark Layton Email
Vice President in Development and MDL Otilimab @ GSK
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Mark Layton Location
- London, GB
Mark Layton Work
- 2015 -now Vice President in Development and MDL Otilimab @
- 2012 -2015 Head of Discovery Medicine, Immunoinflammation Tau @
- 2006 -2012 Medical Science Director @
- 2008 -2012 Fellow @ FPM
- 2003 -2005 Clinical Expert @ Celltech
- 2000 -2003 Global Clinical Leader @
- 1999 -2000 New Business Development Medical Manager @
- 1998 -1999 Medical Affairs Manager @
- 1989 -1998 NHS Positions, Clinical and Research @
Mark Layton Education
- University of Nottingham
Bachelor of Science (Medicine)
1984-1989
Mark Layton Skills
- Clinical Research
- Clinical Trials
- Medical Affairs
- Clinical Development
- Drug Development
- Pharmaceutical Industry
- Medicine
- Infectious Diseases
- Oncology
- Life Sciences
- Pharmacovigilance
- Medical Writing
- Biotechnology
- CRO
- GCP
- R&d
- CRO Management
- Good Clinical Practice Gcp
- Good Clinical Practice
Mark Layton Summary
- Mark Layton, based in London, GB, is currently a Vice President in Development and MDL Otilimab at GSK. Mark Layton brings experience from previous roles at GSK, Astrazeneca, FPM and Celltech. Mark Layton holds a 1984 - 1989 Bachelor of Science in Medicine @ University of Nottingham. With a robust skill set that includes Clinical Research, Clinical Trials, Medical Affairs, Clinical Development, Drug Development and more. Mark Layton has 1 emails on RocketReach.
Looking for a different Mark Layton?
Find contact details for 700 million professionals.
Others Named Mark Layton
Mark Layton
Managing Member
Las Vegas, NV, US
Mark Layton
Shipping Manager
Orangeburg, NY, US
Mark Layton
Vice President
Detroit, MI, US
Mark Layton
Chief Sales Officer (CSO)
Lehi, UT, US
Mark Layton
Editor
London, GB
Top GSK Employees
Anthony Rowe
VP Onyx Research
United Kingdom
Regis Simard
President Global Supply Chain
England, United Kingdom
Theo Faul
VP Commercial Portfolio Strategy and Operations, General Medicines
London, England, GB
Roanne Parry
Chief People Officer
United Kingdom
Shane Renders
SVP GSF Transformation Lead
London, GB
Maurizio Borgatta
VP and Chief Operations Officer
United Kingdom
Neil Wilkinson
CFO, GSK Commercial
Wokingham, GB
Neil Falkingham
Chief Compliance Officer
London, GB
Julie Brown
Chief Financial Officer and Executive Director
United Kingdom
Tony Wood
Chief Scientific Officer
United Kingdom
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co